122 related articles for article (PubMed ID: 2459075)
1. Immunopharmacological activities of chemically synthesized lipid A-subunit analogue GLA-27 combined with muramyl dipeptide via spacers of different carbon chain length.
Ikeda S; Kumazawa Y; Sai K; Nishimura C; Nakatsuka M; Homma JY; Yamamoto A; Kiso M; Hasegawa A
Int J Immunopharmacol; 1988; 10(4):339-46. PubMed ID: 2459075
[TBL] [Abstract][Full Text] [Related]
2. Antiviral and immunomodulating activities of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-60.
Ikeda S; Nishimura C; Nakatsuka M; Homma JY; Kiso M; Hasegawa A
Antiviral Res; 1988; 9(1-2):37-46. PubMed ID: 3389769
[TBL] [Abstract][Full Text] [Related]
3. Effect of stereospecificity of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-40 on the expression of immunopharmacological activities.
Kumazawa Y; Ikeda S; Takimoto H; Nishimura C; Nakatsuka M; Homma JY; Yamamoto A; Kiso M; Hasegawa A
Eur J Immunol; 1987 May; 17(5):663-7. PubMed ID: 3495442
[TBL] [Abstract][Full Text] [Related]
4. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
Kumazawa Y; Nakatsuka M; Takimoto H; Furuya T; Nagumo T; Yamamoto A; Homma Y; Inada K; Yoshida M; Kiso M
Infect Immun; 1988 Jan; 56(1):149-55. PubMed ID: 3257202
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant activities of synthetic lipid A subunit analogues and its conjugates with muramyl dipeptide derivatives.
Maeda H; Saiki I; Ishida H; Kiso M; Hasegawa A; Azuma I
Vaccine; 1989 Jun; 7(3):275-81. PubMed ID: 2675486
[TBL] [Abstract][Full Text] [Related]
6. Effect of acyl substituents of synthetic lipid A-subunit analogues on their immunomodulating antiviral activity.
Ikeda S; Nishimura C; Matsuura M; Homma JY; Kiso M; Hasegawa A
Antiviral Res; 1990 Jun; 13(6):327-33. PubMed ID: 1699495
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for inducing in vitro B lymphocyte activation by chemically synthesized derivatives related to the nonreducing D-glucosamine subunit of lipid A.
Kumazawa Y; Matsuura M; Maruyama T; Homma JY; Kiso M; Hasegawa A
Eur J Immunol; 1986 Sep; 16(9):1099-103. PubMed ID: 3489621
[TBL] [Abstract][Full Text] [Related]
8. Non-specific protective activity of synthetic lipid A-subunit analogs against microbial infections is influenced by their 2-N- and 3-O-linked acyl substituents in the D-glucosamine backbone.
Ikeda S; Matsuura M; Nakatsuka M; Homma JY; Kiso M; Hasegawa A; Nishimura C
J Clin Lab Immunol; 1990 Aug; 32(4):177-81. PubMed ID: 1966934
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of nonspecific resistance to microbial infections of synthetic lipid A-subunit analogues of GLA-27 modified at the C1 position of the glucosamine backbone.
Nakatsuka M; Ikeda S; Kumazawa Y; Matsuura M; Nishimura C; Homma JY; Kiso M; Hasegawa A
Int J Immunopharmacol; 1990; 12(6):599-603. PubMed ID: 1703131
[TBL] [Abstract][Full Text] [Related]
10. Effects of backbone structures and stereospecificities of lipid A-subunit analogues on their biological activities.
Matsuura M; Kojima Y; Homma JY; Kumazawa Y; Yamamoto A; Kiso M; Hasegawa A
J Biochem; 1986 May; 99(5):1377-84. PubMed ID: 3486867
[TBL] [Abstract][Full Text] [Related]
11. Protective activity of lipid A analogue GLA-60 against murine cytomegalovirus infection in mice.
Ikeda S; Neyts J; Matsuura M; Kiso M; Hasegawa A; Nishimura C; De Clercq E
J Med Virol; 1993 Jul; 40(3):222-7. PubMed ID: 8394873
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of nonspecific resistance to viral infection by chemically synthesized lipid A-subunit analogs with different backbone structures and acyl groups.
Ikeda S; Kumazawa Y; Nishimura C; Nakatsuka M; Homma JY; Kiso M; Hasegawa A
Antiviral Res; 1988 Dec; 10(4-5):167-78. PubMed ID: 2465734
[TBL] [Abstract][Full Text] [Related]
13. Antitumor and antimicrobial activities of lipid A-subunit analogue GLA-27.
Nakatsuka M; Kumazawa Y; Ikeda S; Yamamoto A; Nishimura C; Homma JY; Kiso M; Hasegawa A
J Clin Lab Immunol; 1988 May; 26(1):43-7. PubMed ID: 3184160
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of nonspecific resistance to bacterial infections and tumor regressions by treatment with synthetic lipid A-subunit analogs. Critical role of N- and 3-O-linked acyl groups in 4-O-phosphono-D-glucosamine derivatives.
Nakatsuka M; Kumazawa Y; Matsuura M; Homma JY; Kiso M; Hasegawa A
Int J Immunopharmacol; 1989; 11(4):349-58. PubMed ID: 2777430
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of synthetic lipid A analogs and muramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
Shimizu T; Ohtsuka Y; Yanagihara Y; Itoh H; Nakamoto S; Achiwa K
Int J Immunopharmacol; 1991; 13(5):605-11. PubMed ID: 1783474
[TBL] [Abstract][Full Text] [Related]
16. Effect of methyl esterification of isoglutamine residue in 6-O-acylated muramyl dipeptides on expression of immunopharmacological activities.
Furuya T; Kumazawa Y; Takimoto H; Nagumo T; Kiso M; Hasegawa A; Nomoto K
Int J Immunopharmacol; 1991; 13(5):573-7. PubMed ID: 1783471
[TBL] [Abstract][Full Text] [Related]
17. Immunostimulatory activity of 1-O-acylated muramyl dipeptides, with or without a 6-O-phosphoryl group, in aqueous form.
Furuya T; Kumazawa Y; Takimoto H; Nagumo T; Nagamine T; Aizawa C; Mizunoe K; Kiso M; Hasegawa A; Nomoto K
Int J Immunopharmacol; 1989; 11(1):35-43. PubMed ID: 2496044
[TBL] [Abstract][Full Text] [Related]
18. Effect of chemical modification at C1 of the glucosamine backbone of lipid A-subunit analog GLA-27 on manifestation of immunopharmacological activity.
Kumazawa Y; Takimoto H; Yamamoto A; Homma JY; Ogawa Y; Kiso M; Hasegawa A
FEBS Lett; 1988 Oct; 239(1):117-20. PubMed ID: 3181417
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies between liposomes containing muramyl dipeptide and various immunomodulators on activation of mouse peritoneal macrophages and NK cells.
Sakita M; Kageyama N; Majima S
Oncology; 1985; 42(4):259-64. PubMed ID: 4011111
[TBL] [Abstract][Full Text] [Related]
20. Effect of N-acetyl-muramyl-L-alanyl-D-isoglutamine on interferon production in mice by Newcastle disease virus.
Sakuma T; Azuma M; Yoshida I
J Gen Virol; 1984 May; 65 ( Pt 5)():999-1003. PubMed ID: 6202835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
